AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
HYDROCHLOROTHIAZIDE / IRBESARTAN
13 registrations across 2 African markets— 13 active
Markets with HYDROCHLOROTHIAZIDE / IRBESARTAN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| IRBESARTAN/HYDROCHLOROTHIAZIDE IMPACT TABLET, COATED; ORAL | 🇿🇼Zimbabwe | SANOFI AVENTIS SOUTH AFRICA (PTY) | active | Jun 2031 |
| IRBESARTAN/HYDROCHLOROTHIAZIDE IMPACT TABLET, COATED; ORAL | 🇿🇼Zimbabwe | SANOFI AVENTIS SOUTH AFRICA (PTY) | active | Jun 2031 |
| IRBIS-HT TABLET, COATED; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Apr 2031 |
| IRBIS-HT TABLET, COATED; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Apr 2031 |
| CO-APROVEL comprimé pelliculé / 12,5 mg / 300 mg | 🇸🇳Senegal | SANOFI AVENTIS | active | — |
| CO-VEPRAN comprimé / B/28 | 🇸🇳Senegal | WEST AFRIC PHARMA | active | — |
| COAPROZAR comprimé pelliculé / 25 mg / 300 mg | 🇸🇳Senegal | TERIAK | active | — |
| IRBESARTAN / HYDROCHLOROTHIAZIDE BIOGARAN comprimé pelliculé / 25 mg / 300 mg | 🇸🇳Senegal | BIOGARAN | active | — |
| CO-VEPRAN comprimé / 25 mg / 300 mg | 🇸🇳Senegal | WEST AFRIC PHARMA | active | — |
| CO-APROVEL comprimé / 12,5 mg / 150 mg | 🇸🇳Senegal | SANOFI PHARMA BMS SNC | active | — |
| COAPROZAR comprimé pelliculé / 12,5 mg / 150 mg | 🇸🇳Senegal | TERIAK | active | — |
| COAPROVEL comprimé / 25 mg / 300 mg | 🇸🇳Senegal | SANOFI PHARMA BMS SNC | active | — |
| COAPROZAR comprimé pelliculé / 12,5 mg / 300 mg | 🇸🇳Senegal | TERIAK | active | — |
HYDROCHLOROTHIAZIDE / IRBESARTAN in Africa — Regulatory Overview
HYDROCHLOROTHIAZIDE / IRBESARTAN is registered across 2 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 13 registrations, 13 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.